![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Scott John Hsu Henry
Publisher: Taylor & Francis Ltd
ISSN: 1054-3406
Source: Journal of Biopharmaceutical Statistics, Vol.21, Iss.2, 2011-03, pp. : 196-201
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
US FDA issues not approvable letter for istradefylline.
Inpharma, Vol. 1, Iss. 1628, 2008-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Lindane: FDA issues public health advisory
Inpharma, Vol. 1, Iss. 1381, 2003-01 ,pp. :